Recently celebrating ten years in operation, Hampton University Proton Therapy Institute (HUPTI) has treated more than 3,100 patients to date and is the largest free-standing proton therapy cancer center in the world. HUPTI has also led most COMPPARE partner sites in patient enrollment over the past year, with plans…
A Message from Dr. Nancy Mendenhall COMPPARE has achieved both a remarkable overall accrual rate and a remarkable accrual rate of minorities. In fact, the study stands to become a model for patient-centric clinical research in the future. Read Dr. Mendenhall’s message. Partner Site…
Dr. Nancy Mendenhall, COMPPARE Principal Investigator, and Charles Griggs, Minority Engagement Group Coordinator, have been invited to participate in the seventh annual meeting of the Patient-Centered Outcomes Research Institute (PCORI), to be held virtually in November. Dr. Mendenhall and Mr. Griggs will contribute as panelists in a session focused on…
About two million American men undergo conventional transrectal biopsies each year and up to 2,000 of them die from the procedure, mostly from sepsis infections and bleeding complications. Brotherhood of the Balloon, a COMPPARE Partner Organization, told their BOB Tales newsletter…
As we continue to engage partner sites throughout the COMPPARE network, we are pleased to continue our COMPPARE Consortium Spotlight in this newsletter edition, which provides insight into the successes of our partner proton and photon centers across the U.S. The Barbara Ann…
A Message from Dr. Nancy Mendenhall As we look forward to the normal resumption of our work, we ask you to join us in an effort to encourage all men to get back to having their prostates checked annually in order to detect cancers…
On February 17, 2021, Cancer Connections, a UF Monthly Educational & Networking Meeting, presented “COMPPARE Clinical Trial: Protons vs Photons to Treat Prostate Cancer.” Dr. Nancy Mendenhall, M.D., FACR, FASTRO, COMPPARE Principal Investigator, provided an overview of the UF-led national ongoing prostate cancer clinical trial, highlighting the differences between between…
A Message from Dr. Nancy Mendenhall I am thrilled to announce that we have reached 40% of our accrual goal! Our progress is truly astonishing, given the continued challenges COVID-19 has presented us with both globally and locally. Read Dr. Mendenhall’s message. COMPPARE Enrolls…
The COMPPARE team was pleased to announce on November 13, 2020 that the study had enrolled 1,000 patients, one-third of its 3,000-patient goal. COMPPARE’s partner site, the James M. Slater, MD Proton Treatment & Research Center, Loma Linda, CA, enrolled the 1,000th patient. COMPPARE stands for “A Prospective COMparative Study…
Mr. Charles Griggs and Drs. Nancy Mendenhall and Curtiland Deville participated in “Our Health, Our Voice: Improving Prostate Cancer Outcomes through Participation in Research” on Wednesday, November 4, 2020. The live information session, presented by 100 Black Men of America, Inc., a COMPPARE partner organization, focused on the…
